AbCellera Biologics Inc. (ABCL) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-06

AbCellera Biologics Inc. (ABCL) has filed 7 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-06. 5 Form 8-K material event filings were reported by ABCL in the last 90 days. InsiderAlpha tracks every ABCL SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About AbCellera Biologics Inc. (ABCL)

SEC CIK	0001703057

90-Day SEC Filing Activity

Form 4 filings (90d)	7
Form 8-K filings (90d)	5
Latest Form 4 filing	2026-07-06

Recent ABCL Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-06-03	Booth Andrew	Chief Financial Officer	M — Option exercise	250.0K	$0.19	$48K	SEC
2026-05-14	Montalbano John S.	Director	P — Open-market purchase	20.0K	$4.77	$95K	SEC
2026-02-27	Thermopylae Holdings Ltd.	10% Owner	P — Open-market purchase	38.0K	$3.44	$131K	SEC
2026-02-27	Booth Andrew	Chief Financial Officer	P — Open-market purchase	42.6K	$3.42	$146K	SEC
2026-02-26	Thermopylae Holdings Ltd.	10% Owner	P — Open-market purchase	177.5K	$3.27	$580K	SEC
2024-12-04	Thermopylae Holdings Ltd.	10% Owner	G — Bona-fide gift	286.0K	$0.00	—	SEC
2024-11-25	Hansen Carl L. G.	Chief Executive Officer	M — Option exercise	56.1K	$2.70	$152K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for AbCellera Biologics Inc. (ABCL). Updated in real time as new filings are submitted to the SEC.

Most-Active ABCL Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Montalbano John S.	2	$95K
Booth Andrew	2	$48K
Seely Lynn	1	—
Hayden Michael R	1	—
Sandor Victor	1	—

Recent ABCL Form 8-K Material Events

2026-07-06 — Item 5.02, 9.01 [SEC]
2026-06-17 — Item 8.01, 9.01 [SEC]
2026-06-12 — Item 5.07 [SEC]
2026-06-05 — Item 5.02, 9.01 [SEC]
2026-05-11 — Item 2.02, 7.01, 9.01 [SEC]

Recent Insider Filings

2026-07-06 — Seely Lynn (Director)
2026-07-06 — Sandor Victor (Director)
2026-06-12 — Hayden Michael R (Director)
2026-06-12 — Quake Stephen (Director)
2026-06-12 — Montalbano John S. (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ABCL insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

ABCL Insider Trading — FAQ

What is the latest insider trade for ABCL?: AbCellera Biologics Inc. (ABCL) had 7 insider filings in the last 90 days, with the most recent on 2026-07-06. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying ABCL stock?: 0 insider purchases of ABCL were filed in the last 90 days.
How many insiders are selling ABCL stock?: 0 insider sales of ABCL were filed in the last 90 days.
Where can I see ABCL SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every ABCL SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live ABCL dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.